[HDL mimetics, which include ApoA1 mutants and peptide mimetics of ApoA1, are thought to be 'fast acting' and may show greater benefits especially in acute coronary syndromes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE